News
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
22 Apr 24
News, Eurozone, Commodities, Intraday Update, Markets, Trading Ideas
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
22 Apr 24
Biotech, News, Health Care, Movers, General
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
22 Apr 24
News, Intraday Update, Markets, Movers
Hepion Pharmaceuticals Says Given The Number Of Enrolled NASH Patients To Date And The Low Probability Of Generating Relevant Efficacy Data To Support A Registrational Trial With Our Current Cash Resources, We Have Opted To Wind Down The Program And Assure That Patients Are Transitioned Out Of The Trial In A Safe And Compliant Manner"
19 Apr 24
Biotech, News, General
Hepion Pharmaceuticals Initiates Wind-Down Activities In Phase 2b 'ASCEND-NASH' Trial
19 Apr 24
Biotech, News, General
12 Health Care Stocks Moving In Monday's Pre-Market Session
19 Feb 24
Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
16 Feb 24
Movers
12 Health Care Stocks Moving In Thursday's Intraday Session
15 Feb 24
Movers